Trial intelligence / Profile preview

Pharmacokinetics of Etoricoxib 120 mg vs Arcoxia 120 mg in Healthy Thai Subjects (Fasting, Crossover)

TCTR20190428001Phase 1Completed

Sponsor
Abbott Laboratories
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of etoricoxib (2 arms), sponsored by Abbott Laboratories. Started Jul 2019; status: completed.

02

Drugs

etoricoxib

Beyond the preview

Go deeper on TCTR20190428001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190428001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call